Home Dialysis Systems Market Size, Share, By Product [(Device (Machine, Dialyzers, Water Treatment System, Others), Consumables (Bloodlines, Concentrates, Catheters, Others)], By Type [(Hemodialysis (Conventional, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Ambulatory Peritoneal Dialysis (APD))], By Treatment (Acute Kidney Disease, Chronic Kidney Disease), and By Region - Trends, Analysis and Forecast till 2034
The Home Dialysis Systems market is projected to witness healthy growth, with increasing cases of chronic kidney disease (CKD) and increasing preference for home-based health care. While numerous patients and provider options now exist in-home, such as peritoneal dialysis (PD) and hemodialysis (HD), such forms promote flexibility and improve one's quality of life while reducing hospital visits. Along with the availability of more portable and beginner-friendly dialysis machines, each of these factors is further driving the growth of the market.
Home Dialysis Systems Market Report Highlights:
- By 2034, the target market is expected to grow to USD 42.66 Billion.
- Target market is expanding at a CAGR of 10.7%
- In 2023, Home Dialysis Systems market was estimated to be worth USD 15.6 Billion.
- North America held the largest share of the market in 2024.
- Asia Pacific is projected to be the fastest-growing market in the coming years.
- Based on product, the market is being dominated by the device segment.
- By type, the Hemodialysis is expected to account for the largest share of the Home Dialysis Systems market in upcoming years.
- On the basis of treatment, the chronic kidney disease is the most dominating segment in the market.
Home Dialysis Systems Market Key Highlights:
- In June 2024, Outset Medical unveils new upgrades on its Tablo Hemodialysis System that includes new, improved user interfaces, and better remote monitoring capabilities. According to the company, the new version of Tablo shall provide healthcare providers with access to information 24/7 regarding the safety and outcomes of the patient.
Home Dialysis Systems Market Report Analysis:
Uptake of Home Dialysis in Younger Adults:
Support is necessary for young people thinking about home dialysis to make sure their living conditions are appropriate and reasonably priced. Younger people using home dialysis experiencing financial strain is closely related to their household circumstances. Policymakers, donors, and medical professionals must pay attention to the home situations of younger patients with chronic renal disease.
Home dialysis is linked to better health, freedom, flexibility, and the potential to continue or obtain work. However, less than 15% of patients are receiving haemodialysis and 25% of those are receiving peritoneal or continuous ambulatory peritoneal dialysis, who choose to receive treatment at home. Although a recent meta-analysis of qualitative studies identifying challenges and facilitators to home dialysis acknowledged a gap in knowledge surrounding the home dialysis experience of younger adults, it is generally assumed that younger patients are better suited to home dialysis.
Browse ∼50 market data tables and ∼45 figures through ∼191 slides and in-depth TOC on “Home Dialysis Systems Market Size, Share, By Product [(Device (Machine, Dialyzers, Water Treatment System, and Others) and Consumables (Bloodlines, Concentrates, Catheters, and Others)], By Type [(Hemodialysis (Conventional, Short Daily Hemodialysis, and Nocturnal Hemodialysis) and Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis (APD))], By Treatment (Acute Kidney Disease and Chronic Kidney Disease), and Region - Trends, Analysis, and Forecast till 2034”
Home Dialysis Systems Market Competitive Landscape:
The key players operating in the home dialysis systems market include Fresenius Medical Care, Baxter International Inc., Outset Medical, Inc., Quanta Dialysis Technologies, NxStage Medical, Medtronic plc, B. Braun Melsungen AG, Asahi, Kasei Corporation, Nipro Corporation, Teleflex Incorporated, DaVita Inc., JMS Co. Ltd., Toray Medical Co., Ltd., Dialife SA, Kawasumi Laboratories, Inc.